• 为全球30多个国家提供兽医产品和服务

定了!布尔药业新基地设计图纸完成审批,明年年底投入生产

为了迎合国家农业部今年发布的新版GMP要求以及医药行业智能化生产的指示,公司获得荣昌高新区40亩工业用地,经过两个月的商业会谈、协议签订以及建设方案论证,目前完成了工程的平面设计、建筑设计和工艺设计,制作完成了主体建筑效果图并获得审批。

The design drawings of the new production base of Bullvet have been approved and put into production at the end of next year

为了迎合国家农业部今年发布的新版GMP要求以及医药行业智能化生产的指示,公司获得荣昌高新区40亩工业用地,经过两个月的商业会谈、协议签订以及建设方案论证,目前完成了工程的平面设计、建筑设计和工艺设计,制作完成了主体建筑效果图并获得审批。

In order to meet the new version GMP issued by the Ministry of Agriculture and the instructions for intelligent production in the pharmaceutical industry, Bullvet has obtained 2.6 Hectares of industrial land in Rongchang High-tech Zone. After business talks, agreement signing, and demonstration of construction plans nearly two months, now we has completed the graphic design, architectural design and process design of the project, and completed the main building renderings.

布尔厂房--透视.jpg

科研及商务中心

The center of R&D and business

布尔厂房--鸟瞰.jpg

由前向后:科研及商务中心、制剂大楼、消毒剂车间、辅助用房、饲料及预混剂车间、实验大楼

The center of R&D & business, preparation building, disinfectant workshop, auxiliary room, feed and premix workshop, laboratory building

新生产基地共计建设23000平方米,设计有研发中心、质检中心、商务中心、制剂大楼、饲料、预混剂、消毒剂等主要生产设施。建成后,将可以生产大容量注射液、小容量注射液、内服液体制剂(含溶液剂、混悬剂、乳剂)、外用液体制剂(含酊剂、醑剂)、半固体制剂(软膏、糊剂)、粉剂、颗粒剂、片剂、预混剂等10几种剂型十余条生产线,工程总投资5000万元,预计在2021年年底完工并投入试生产。届时,新基地的建成将结束公司目前办公、生产、库房分散,不便于管理的困境,为员工提供更为高效、快速、舒适、便利的工作环境。新基地的投入将使生产能力提高2倍以上,产值突破1亿元。

The new production base has a total construction of 23,000 square meters, and is designed with scientific research building, quality inspection center, commerce center, preparation building, feed, premix, disinfectant and other major production facilities. After completion, it will be able to produce large-volume injections, small-volume injections, liquid preparations for oral administration, liquid preparations for external use , and semi-solid preparations, powders, granules, tablets and bolus , premixes, etc. There are more than ten production lines with 10 dosage forms. The total project investment is 10 million USD. It is expected to be completed and put into trial production by the end of 2021.  The investment in the new base will increase the production capacity by more than two times, and the output value will exceed 20 million USD.